Status:

RECRUITING

Integrated HPV Vaccination and Adolescent Health in Ivory Coast

Lead Sponsor:

Jhpiego

Conditions:

Integrated Care

HPV Vaccination

Eligibility:

All Genders

9-110 years

Phase:

NA

Brief Summary

Background: Cervical cancer is a serious global public health problem, particularly in sub-Saharan Africa, where it is the leading cause of cancer in women, with around 70,722 new cases each year. Vac...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for adolescents:
  • Age: 9 to 15;
  • Residence in the study regions;
  • Parental or guardian permission is required;
  • Provides assent and agrees to participate in the study.
  • Inclusion criteria for Parents/caregivers:
  • Be the parent or legal guardian of an adolescent aged 9 to 15 years;
  • Residence in the study regions;
  • Provides informed consent and agrees to participate in the study.
  • Exclusion Criteria:
  • People who have time constraints;
  • those who do not speak French or the prominent dialects in study regions;
  • those unable to participate because ill, intoxicated or appearing psychologically impaired;
  • those residing outside study health regions;
  • those who do not provide consent/assent to participate.

Exclusion

    Key Trial Info

    Start Date :

    March 16 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2025

    Estimated Enrollment :

    3384 Patients enrolled

    Trial Details

    Trial ID

    NCT06997705

    Start Date

    March 16 2025

    End Date

    September 1 2025

    Last Update

    May 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    École Nationale Supérieure de Statistique et d'Économie Appliquée (ENSEA)

    Abidjan, Côte d’Ivoire